Financials
- Market Capitalization 2.17 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-18.43
Relación precio/flujo de caja
10.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1918 | MESO Mesoblast Limited - American Depositary Shares | 17.29 USD | +4.79% | -2.97% | +17.78% | +31.98% | 2.24 B USD | ||
| 1937 | ZYME Zymeworks Inc. - Common Stock | 31.05 USD | +4.65% | +5.90% | +38.55% | +75.03% | 2.20 B USD | ||
| 1945 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | +1.50% | -1.09% | +9.99% | +36.55% | 2.17 B USD | ||
| 1951 | ZBIO Zenas BioPharma, Inc. - Common Stock | 33.13 USD | +3.60% | +0.98% | +6.56% | +25.21% | 2.16 B USD |